Stem Cell Labs — Topics

S I T E M A P

HOME	FAQ	FEEDBACK	PRODUCTS	TOPICS	GLOSSARY	FORUMS	EDUCATION	License our Technology

USA ONLY: The mesenchymal and umbilical cord blood stem cells used in this study are human cells, tissues, or cellular and tissue-based products (HCT/Ps) as defined in 21 CFR § 1271.3(d). Under 21 CFR Part 1271, HCT/Ps are not subject to licensure or IND requirements if certain criteria are met (21 CFR § 1271.10). These requirements include autologous use (use by the cell donor), or if used for other patients, the HCT/Ps must be “not more than minimally manipulated” and labeled for use for “homologous use only”. They may also not be used for a purpose requiring their “metabolic” activity. StemLab S.A. mesenchymal and umbilical cord stem cells shipped to the United States of America have not been “more than minimally manipulated”. StemLab S.A. labels and intends its cells which are used within the United States of America only for homologous and non-metabolic purposes. StemLab S.A. does not interfere with the practice of medicine by individual physicians who use StemLab products, and who may do so according to their own medical training and informed choice.

GGT

www.GlobalGeniusTrust.com

StemTech Labs is a Global Genius Trust company

Webmaster: Jack Crompton | SPIRAL DREAM – a media partner of Global Genius Trust

Stem Cells — Topics

Our Lines of Research in Stem Cell Therapy

At StemTech Labs, we have several exciting lines of research underway.

Some of these projects are as follows:

• Improve effectiveness of basic stem cell separation and processing.

• Begin stem cell expansion, to increase total available cells.

• Develop a more effective regimen for Lung cell precursors,
to treat emphysema and other disorders.

• Augmenting the amounts of mesenchymal stem cells in
umbilical cord blood by harvesting them from umbilical cords.

• Differentiation of Mesenchymal stem cells into neural stem
cells, liver, kidney, and other precursor cells.

Increasing ability to follow the morphogenetic pattern of the body.

	Every living thing has an energetic pattern, or morphogenetic field. Cells use this field as a pattern to build a body.

ORMUS

ORMUS/ORMES is a unique form of matter.

www.subtleenergies.com/ormus

	Ormus has been shown to markedly improve vitality and decrease mortality in chickens, yeast cultures, plants, and humans. As evidenced in this photo, It has shown to increases crop yields by 100+%.

Increasing Stem Cell Viability

In 250,000 broiler chicks, minute amounts of Ormus decreased many diseases and lowered mortality. Ormus added in very small amounts to yeast cultures increased alcohol tolerance up to 37% alcohol. We hope that Ormus will increase the vitality of our stem cell lines.

Salamander cells use the field to duplicate an amputated limb, but higher animals have not been able to regenerate limbs.

	A Newt can regenerate an entire limb withing 7-10 weeks.

Ormus and Regeneration

Ormus appears to be able to increase stem cells’ ability to regenerate the body, following the morphogenetic field. See the following photos of a cat with a severed tail, which regenerated an entire tail.

	Stub of cat’s tail, with severed part.

	Ormus-treated ball of stem cells is creating a new tail – skin, bone, muscle, nerves.

	Adult cat with regenerated tail.

Live Cell Therapy

Since the 1920s, Europeans have used live fetal animal cells to stimulate healing in human patients. Live fetal cells have been shown to travel to like cells in the human body, similarly to the actions of stem cells. Once arrived, the cells stimulate the cells in the damaged human tissue to repair and regenerate.

While most famous for its regenerative and anti-aging aspects, disorders such as diabetes and endocrine dysfunctions have been cured using live cell therapy, and other diseases such as emphysema have been successfully treated, producing results faster than stem cell transplants. This therapy is not available in the U.S.A. at this time, but is available in several other countries.

We hope that we might be able to duplicate the success of Live Cell Therapy with umbilical cord stem cells, instead of fetal animal cells, or possibly use a combination of the two therapies.

• Differentiating stem cells into Liver/Pancreas precursors, to heal diabetes.

• Producing Neural Stem Cells for brain and spinal cord injury,
MS, ALS, Cerebral Palsy, Parkinson’s Disease, and other disorders.

O T H E R T O P I C S